EDTXF (Spectral Medical) E10: $-0.04 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EDTXF Spectral Medical Inc EDTXF
10 GF Score
Price $0.95
GF Value $0.65
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Spectral Medical E10?

Spectral Medical EDTXF 10 E10 is $-0.04 as of Mar. 2026. GuruFocus rates EDTXF with a GF Score™ of 10/100 and a GF Value™ of $0.65 (Significantly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Spectral Medical's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.007. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.04 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Spectral Medical was 41.50% per year. The lowest was -51.80% per year. And the median was 13.05% per year.

As of today (2026-07-15), Spectral Medical's current stock price is $0.95. Spectral Medical's E10 for the quarter that ended in Mar. 2026 was $-0.04. Spectral Medical's Shiller PE Ratio of today is .


Spectral Medical  (OTCPK:EDTXF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Spectral Medical E10 Related Terms


Spectral Medical E10 Historical Data

* Premium members only.

The historical data trend for Spectral Medical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spectral Medical E10 Chart

Spectral Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.03 0.00

Spectral Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 0.00 -0.04 0.00 -0.04

EDTXF vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Spectral Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Shiller PE Ratio falls into.


EDTXF
10GF Score
Spectral Medical Inc EDTXF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spectral Medical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Spectral Medical's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.007/132.2623*132.2623
=-0.007

Current CPI (Mar. 2026) = 132.2623.

Spectral Medical Quarterly Data

per share eps CPI Adj_EPS
201606 -0.016 102.002 -0.021
201609 -0.008 101.765 -0.010
201612 -0.007 101.449 -0.009
201703 -0.004 102.634 -0.005
201706 -0.005 103.029 -0.006
201709 -0.003 103.345 -0.004
201712 -0.005 103.345 -0.006
201803 -0.002 105.004 -0.003
201806 -0.005 105.557 -0.006
201809 -0.002 105.636 -0.003
201812 0.002 105.399 0.003
201903 -0.003 106.979 -0.004
201906 -0.004 107.690 -0.005
201909 -0.005 107.611 -0.006
201912 -0.004 107.769 -0.005
202003 -0.011 107.927 -0.013
202006 -0.007 108.401 -0.009
202009 -0.005 108.164 -0.006
202012 -0.008 108.559 -0.010
202103 -0.006 110.298 -0.007
202106 -0.008 111.720 -0.009
202109 -0.006 112.905 -0.007
202112 -0.004 113.774 -0.005
202203 -0.008 117.646 -0.009
202206 -0.008 120.806 -0.009
202209 -0.007 120.648 -0.008
202212 -0.015 120.964 -0.016
202303 -0.007 122.702 -0.008
202306 -0.015 124.203 -0.016
202309 -0.007 125.230 -0.007
202312 -0.022 125.072 -0.023
202403 -0.007 126.258 -0.007
202406 -0.015 127.522 -0.016
202409 -0.030 127.285 -0.031
202412 0.014 127.364 0.015
202503 -0.028 129.181 -0.029
202506 0.000 129.892 0.000
202509 -0.080 130.287 -0.081
202512 0.000 130.366 0.000
202603 -0.007 132.262 -0.007

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.04 mean?
Spectral Medical (EDTXF) has a E10 of $-0.04 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Spectral Medical and its competitors.
Is Spectral Medical's E10 too high?
Spectral Medical's current E10 is $-0.04. Overall, Spectral Medical has a GF Score™ of 10/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral Medical's E10 compare to TMO and DHR?
Spectral Medical's E10 of $-0.04 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Spectral Medical and its competitors. Spectral Medical's current E10 is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral Medical stock overvalued right now?
Based on GuruFocus' analysis, Spectral Medical (EDTXF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.65, compared to a current price of $0.95 — trading 46.2% above its estimated fair value. The current E10 is $-0.04. Spectral Medical's overall GF Score™ is 10/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Spectral Medical (EDTXF), the current E10 is $-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spectral Medical (EDTXF) Overvalued in 2026?

Based on GuruFocus' analysis, Spectral Medical stock appears to be overvalued. The current stock price of $0.95 is trading 46.2% above its estimated GF Value™ of $0.65. GuruFocus considers Spectral Medical to be Significantly Overvalued.

Key valuation signals for EDTXF:

  • E10: $-0.04
  • GF Value™: $0.65 vs. price of $0.95 (46.2% above fair value)
  • GF Score™: 10/100 with 9 warning signs

No single metric tells the full story. See the EDTXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Spectral Medical Business Description

Other Exchanges SD4:GermanyEDT:Canada
Address 135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.
10GF Score

Get the complete analysis for EDTXF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price
$0.65
GF Value